Telix Pharmaceuticals Limited (TLX) Monday said that is has appointed Paul Schaffer to the newly created role of Chief Technology Officer, effective today.
Schaffer has been CTO of ARTMS Inc. (ARTMS), which was acquired by Telix in 2024. He was also the Director, Life Science at TRIUMF, Canadas particle accelerator research centre, since 2012.
Christian Behrenbruch, Telix Managing Director and Group Chief Executive Office, said, "Paul has an impressive track record of driving innovation in life sciences technology, including his groundbreaking work in large-scale isotope production. I have first-hand experience of Pauls impressive intellect, ideas and passion through his work at TRIUMF and with ARTMS, so it is a great pleasure to have him join the broader Telix team as we continue to lead radiopharmaceutical innovation."
For comments and feedback contact: editorial@rttnews.com
Business News
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.